Login to Your Account

Clinic Roundup

Wednesday, August 28, 2013
• Lipidor AB, of Stockholm, a Karolinska Development portfolio firm, reported results from a Phase I/IIa study of AKVANO/calcipotriol spray formulation for the treatment of psoriasis vulgaris, which showed that the water-free spray had clear and significant antipsoriatic effects vs. placebo, comparable to a marketed formulation of calcipotriol, meeting the primary objective of the study.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription